VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Xintong Pharma Files for STAR Market IPO with First-in-Class Liver-Targeted HBV Drug and CNY 900M Fundraising Plan
Xintong Pharma Files for STAR Market IPO with First-in-Class Liver-Targeted HBV Drug and CNY 900M Fundraising Plan
CST Updated Jun 30, 2026 09:56
Share:
